Flexible Solutions reshapes audit committee leadership

Q: What director changes did FSI (FLEXIBLE SOLUTIONS INTERNATIONAL INC.) announce on August 31, 2026?

FSI announced that John Bientjes resigned as a director and audit committee chair, and that Dr. Kim Reid was appointed as a director and audit committee member. The company stated the resignation was not due to any disagreement on operations, policies, or practices.

Q: Who is the new audit committee chair at FSI (FSI) and when was this effective?

David (Dave) Fynn was appointed audit committee chair at FSI effective August 31, 2026. He had already served on the audit committee for many years before assuming the chair role, according to the company’s disclosure.

Q: Why did director John Bientjes resign from FSI’s board?

FSI states that John Bientjes’ resignation as director and audit committee chair on August 31, 2026 was not due to any disagreement on matters relating to the company’s operations, policies, or practices. The company thanked him for nearly thirty years of service.

Q: What is Dr. Kim Reid’s background relevant to her new role at FSI (FSI)?

Dr. Reid is a process development scientist with experience in bio‑manufacturing, molecular biology, health research, GMP procedures, and operational leadership. She holds a PhD in Biology and multiple advanced degrees and diplomas in related fields, and leads an mRNA‑LNP cancer‑vaccine technology transfer team.

Q: Did FSI issue a press release about the board changes on August 31, 2026?

Yes. On August 31, 2026, FSI issued a press release announcing Mr. Bientjes’ resignation as director and audit committee chair and the appointment of Dr. Kim Reid as director and audit committee member. The press release is filed as Exhibit 99.1.

Flexible Solutions International Inc. (FSI) reported board and audit committee changes.

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Flexible Solutions International Inc. (FSI) reported board and audit committee changes. On August 31, 2026, long‑serving director John Bientjes resigned as a director and as chair of the audit committee; the company states his resignation was not due to any disagreement regarding operations, policies, or practices.

The board appointed Dr. Kim Reid as a director and audit committee member, and appointed David (Dave) Fynn as the new audit committee chair. A press release issued the same day highlights Dr. Reid’s background in bio‑manufacturing, molecular biology, GMP environments, and operational leadership, adding scientific and regulatory expertise to the board while acknowledging Mr. Bientjes’ nearly thirty years of service.

Insights

Analyzing...

8-K Event Classification

3 items: 5.02, 8.01, 9.01

3 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Effective date of director resignation: August 31, 2026 Effective date of new director appointment: August 31, 2026 Length of service of resigning director: nearly thirty years +1 more

4 metrics

Effective date of director resignation August 31, 2026 Date John Bientjes resigned as director and audit committee chair

Effective date of new director appointment August 31, 2026 Date Dr. Kim Reid was appointed director and audit committee member

Length of service of resigning director nearly thirty years Approximate tenure of John Bientjes on the board as described in the press release

Year FSI entered food and nutrition markets 2022 Year the Peru IL plant obtained FDA food grade approval

Key Terms

audit committee, GMP bio-manufacturing, mRNA-LNP cancer-vaccine, forward-looking statements, +1 more

5 terms

audit committee financial

"Mr. Bientjes also served as Audit Committee Chair; Mr. David Fynn..."

A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.

GMP bio-manufacturing medical

"bring mRNA-LNP cancer-vaccine production from academia into scaled GMP bio-manufacturing."

mRNA-LNP cancer-vaccine medical

"to bring mRNA-LNP cancer-vaccine production from academia into scaled GMP..."

forward-looking statements regulatory

"Certain of the statements contained herein, which are not historical facts, are forward looking statements..."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

Safe Harbor regulatory

"The Private Securities Litigation Reform Act of 1995 provides a “Safe Harbor” for forward-looking statements."

Safe harbor is a rule that protects companies or individuals from legal trouble if they follow certain guidelines or procedures. It’s like having a safety net that allows them to act without fear of punishment, as long as they stick to the rules. This helps encourage honest behavior and clear standards in financial and legal activities.

FAQ

What director changes did FSI (FLEXIBLE SOLUTIONS INTERNATIONAL INC.) announce on August 31, 2026?

FSI announced that John Bientjes resigned as a director and audit committee chair, and that Dr. Kim Reid was appointed as a director and audit committee member. The company stated the resignation was not due to any disagreement on operations, policies, or practices.

Who is the new audit committee chair at FSI (FSI) and when was this effective?

David (Dave) Fynn was appointed audit committee chair at FSI effective August 31, 2026. He had already served on the audit committee for many years before assuming the chair role, according to the company’s disclosure.

Why did director John Bientjes resign from FSI’s board?

FSI states that John Bientjes’ resignation as director and audit committee chair on August 31, 2026 was not due to any disagreement on matters relating to the company’s operations, policies, or practices. The company thanked him for nearly thirty years of service.

What is Dr. Kim Reid’s background relevant to her new role at FSI (FSI)?

Dr. Reid is a process development scientist with experience in bio‑manufacturing, molecular biology, health research, GMP procedures, and operational leadership. She holds a PhD in Biology and multiple advanced degrees and diplomas in related fields, and leads an mRNA‑LNP cancer‑vaccine technology transfer team.

Did FSI issue a press release about the board changes on August 31, 2026?

Yes. On August 31, 2026, FSI issued a press release announcing Mr. Bientjes’ resignation as director and audit committee chair and the appointment of Dr. Kim Reid as director and audit committee member. The press release is filed as Exhibit 99.1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/01/2026 - 02:42 PM Accepted by SEC EDGAR 09/01/2026 - 02:42 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): August 31, 2026

FLEXIBLE SOLUTIONS INTERNATIONAL INC.

(Exact name of Registrant as specified in its charter)

Alberta

001-31540

71 163 0889

(State or other jurisdiction

of incorporation)

(Commission

File No.)

(Employer

Identification No.)

6001 54 Ave.

Taber, Alberta, Canada T1G 1X4

(Address of principal executive offices, including Zip Code)

Registrant’s telephone number, including area code: (250) 477-9969

N/A

(Former name or former address if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of exchange on which registered
Common Stock		FSI		NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§204.12b-2 of this chapter.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 31, 2026:

John Bientjes resigned as a director of the Company and as the chairman of the Company’s audit committee.

Dr. Kim Reid was appointed a director of the Company and as a member of the Company’s audit committee.

Davis Fynn was appointed as a chairman of the audit committee.

The resignation of Mr. Bientjes was not due to any disagreement on any matter relating to the Company’s operations, policies, or practices.

Item 8.01

Other Events

On August 31, 2026, the Company issued a press release announcing the resignation of Mr. Bientjes as a director and the appointment of Mr. Reid as a director.

Item 9.01

Exhibits

Exhibit

Number

Description of Document

99.1

August 31, 2026 Press Release

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:	September 1, 2026	FLEXIBLE SOLUTIONS INTERNATIONAL INC.

		By:	/s/ Daniel B. O’Brien
			Daniel B. O’Brien, President and Chief Executive Officer

EXHIBIT 99.1

NEWS RELEASE

August 31, 2026

FSI announces the appointment of Dr. Kim Reid as director

TABER, ALBERTA, August 31, 2026– FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE-AMERICAN: FSI), is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient availability chemistry. Flexible Solutions also manufactures biodegradable and environmentally safe water and energy conservation technologies. In addition, FSI is increasing its presense in the food and nutrition supplement manufacturing markets. Today the Company wishes to announce the appointment of Dr. Kim Reid as director and audit committee member.

“The Board of Directors wishes to announce the resignation of Director John Bientjes after nearly thirty years of service. We are sad to lose his official advice but, John will remain as a friend and confidant of the Company. Mr. Bientjes also served as Audit Committee Chair; Mr. David Fynn, who has been on the Audit Committee for many years, has accepted the Audit Committee Chair position.

We are also pleased to announce the appointment of Dr. Kim Reid as Director and Audit Committee member, to serve until the next Annual Meeting. Dr. Reid is a process development scientist with a background in bio-manufacturing, molecular biology, health research, and operational leadership. She is currently a Postdoctoral Fellow in the John C. Bell Laboratory at the Ottawa Hospital Research Institute, where she leads a technology transfer team to bring mRNA-LNP cancer-vaccine production from academia into scaled GMP bio-manufacturing. She has experience in upstream and downstream process development, assay development, quality control and assurance, GMP clean-room procedures, bioreactors, filtration, chromatography and fill-and-finish. She holds a PhD in Biology from the University of Ottawa, an MSc in Experimental Pathology and Laboratory Medicine from UBC, an Advanced Biotechnology Diploma from Algonquin College, a BSc in Biology, and a combined BSc in Physics and Physical Oceanography. She has completed specialized training in GMP and mRNA/mRNA-LNP biomanufacturing.

Kim’s research has been published in peer-reviewed journals including Scientific Reports, Journal of Biological Chemistry, and Endocrinology, and her work as a freelance systematic reviewer has involved leading multidisciplinary teams in the examination of clinical and health-economics evidence for international clients. Her current professional engagement includes founding and leading the Expert Talk Series for the Society for RNA Therapeutics. Early in her career, Kim served with the Royal Canadian Air Force as an officer and fighter pilot, flying the CT-114 Tutor, CF-5 Freedom Fighter and CF-18 Hornet with 441 Tactical Fighter Squadron. She was the third woman to fly fighter aircraft in Canada and the first woman to become operationally qualified for both NORAD and NATO combat missions. Her experience will allow her to contribute to scientific and board discussions, particularly where technology, innovation, risk, regulated environments, evidence-based decision-making and organizational leadership intersect.

We are excited to welcome Dr. Reid and feel sure that she will add depth and new skills to the Board.

Once again, we would like to thank John personally for all his years of service and friendship.”

About Flexible Solutions International

Flexible Solutions International, Inc. (www.flexiblesolutions.com), based in Taber, Alberta, is an environmental technology company. The Company’s NanoChem Solutions Inc. subsidiary specializes in biodegradable, water-soluble products utilizing thermal polyaspartate (TPA) biopolymers. TPA beta-proteins are manufactured from the common biological amino acid, L-aspartic and have wide usage including scale inhibitors, detergent ingredients, water treatment and crop enhancement. Along with TPA, this division started producing other crop enhancement products as well. In 2022, the Company entered the food and nutrition markets by obtaining FDA food grade approval for the Peru IL plant. The other divisions manufacture energy and water conservation products for drinking water, agriculture, industrial markets and swimming pools throughout the world.

Safe Harbor Provision

The Private Securities Litigation Reform Act of 1995 provides a “Safe Harbor” for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward looking statement with respect to events, the occurrence of which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s reports filed with the Securities and Exchange Commission.

Flexible Solutions International

6001 54^th Ave, Taber, Alberta, CANADA T1G 1X4

Company Contacts

Jason Bloom

Toll Free: 800.661.3560

Fax: 403.223.2905

Email: info@flexiblesolutions.com

To find out more information about Flexible Solutions and our products please visit www.flexiblesolutions.com

If you have received this news release by mistake or if you would like to be removed from our update list please reply to: info@flexiblesolutions.com

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

5 documents